CD47 and non-Hodgkin lymphoma: In adults, high tumor CD47 expression correlates with poor progression-free and overall survival in cancer patients, including adult patients with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), non-Hodgkin’s lymphoma, Sézary syndrome, ovarian cancer, breast cancer, squamous cell carcinomas, gliomas, and astrocytomas[4,5,26-31].